Athira Inks $4M FCA Deal Over Ex-CEO's Research Fraud

By Rae Ann Varona · January 6, 2025, 11:05 PM EST

Athira Pharma Inc. has agreed to pay $4 million to resolve allegations it used falsified academic research papers on neurological disorders like Alzheimer's to secure federal grants from the National Institute...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

United States of America et al v. Athira Pharma Inc

Case Number

2:21-cv-00853

Court

Washington Western

Nature of Suit

Qui Tam (31 U.S.C. § 3729(a))

Date Filed

June 24, 2021